PL2876113T3 - Sposób wytwarzania rekombinowanego peptydu i uzyskany peptyd - Google Patents

Sposób wytwarzania rekombinowanego peptydu i uzyskany peptyd

Info

Publication number
PL2876113T3
PL2876113T3 PL13772776T PL13772776T PL2876113T3 PL 2876113 T3 PL2876113 T3 PL 2876113T3 PL 13772776 T PL13772776 T PL 13772776T PL 13772776 T PL13772776 T PL 13772776T PL 2876113 T3 PL2876113 T3 PL 2876113T3
Authority
PL
Poland
Prior art keywords
peptide
producing
resultant
recombinant
recombinant peptide
Prior art date
Application number
PL13772776T
Other languages
English (en)
Inventor
Nikolay Fedorovich Myasoedov
Lyudmila Alexandrovna Andreeva
Dmitriy Viktorovich GOLIKOV
Original Assignee
"Ivix" Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Ivix" Company Limited filed Critical "Ivix" Company Limited
Publication of PL2876113T3 publication Critical patent/PL2876113T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL13772776T 2012-03-28 2013-05-28 Sposób wytwarzania rekombinowanego peptydu i uzyskany peptyd PL2876113T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012111965A RU2507212C3 (ru) 2012-03-28 2012-03-28 Способ получения рекомбинантного пептида и полученный пептид
EP13772776.4A EP2876113B1 (en) 2012-03-28 2013-05-28 Method for producing a recombinant peptide and resultant peptide
PCT/RU2013/000433 WO2013151467A2 (ru) 2012-03-28 2013-05-28 Способ получения рекомбинантного пептида и полученный пептид

Publications (1)

Publication Number Publication Date
PL2876113T3 true PL2876113T3 (pl) 2020-06-15

Family

ID=49301137

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13772776T PL2876113T3 (pl) 2012-03-28 2013-05-28 Sposób wytwarzania rekombinowanego peptydu i uzyskany peptyd

Country Status (12)

Country Link
US (2) US9409947B2 (pl)
EP (2) EP3650457B1 (pl)
BR (1) BR112014023888B1 (pl)
CA (1) CA2868820C (pl)
DK (1) DK2876113T3 (pl)
ES (1) ES2768300T3 (pl)
IL (1) IL234753B (pl)
IN (1) IN2014DN08984A (pl)
PL (1) PL2876113T3 (pl)
PT (1) PT2876113T (pl)
RU (1) RU2507212C3 (pl)
WO (1) WO2013151467A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2507212C3 (ru) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид
RU2655763C2 (ru) * 2016-10-24 2018-05-29 Общество С Ограниченной Ответственностью "Айвикс" Фармацевтическая композиция и способ лечения женских сексуальных дисфункций
RU2626002C1 (ru) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" Новая группа пептидов для лечения женской сексуальной дисфункции
RU2709503C1 (ru) * 2019-05-23 2019-12-18 Акционерное общество "Инновационный научно-производственный центр "Пептоген" (АО "ИНПЦ "Пептоген") Применение пептида thr-lys-pro-arg-pro-gly-pro (селанк) для повышения резистентности организма к острой гипотермии
EP4613260A1 (en) 2022-10-31 2025-09-10 Chemyunion Ltda Compounds and cosmetic, dermocosmetic, cosmeceutical or pharmaceutical compositions for relaxing muscles, including the skeletal muscles of the face, for anti-aging cosmetic action, for reducing and/or smoothing expression lines and wrinkles and/or for antiperspirant action, uses and methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
RU1124544C (ru) * 1983-06-30 1995-01-09 Институт молекулярной генетики РАН Гептапептид, обладающий свойствами психостимулятора пролонгированного действия с иммунотропной активность
RU2058791C1 (ru) 1989-01-11 1996-04-27 Государственное предприятие "Элер-микро" Стимулятор репродуктивной способности у теплокровных животных
US5872100A (en) 1990-05-11 1999-02-16 Deghenghi; Romano Peptides containing D-2-Alkyl-Tryptophan
WO1994022460A1 (en) 1993-04-05 1994-10-13 University Patents, Inc. Diagnosis and treatment of erectile dysfunction
US5932548A (en) 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
RU2155065C1 (ru) 1999-04-23 2000-08-27 Институт молекулярной генетики РАН Анксиолитическое средство и фармацевтическая композиция анксиолитического действия
US6211156B1 (en) 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
RU2252779C1 (ru) 2003-09-23 2005-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Способ профилактики и лечения язв желудочно-кишечного тракта
RU2290195C1 (ru) 2005-04-21 2006-12-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Средство с антикоагулянтной, антитромбоцитарной, антитромботической, фибриндеполимеризационной и фибринолитической активностями
CN101302246B (zh) 2007-05-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 黑色素皮质激素受体七肽类激动剂及其制备方法和用途
KR20100056508A (ko) 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 폐렴 연쇄상 구균 감염의 치료를 위한 bfgf 1-24 및 임의의 (arg 8)바소프레신의 용도
US7618801B2 (en) 2007-10-30 2009-11-17 Danison US Inc. Streptomyces protease
RU2411249C2 (ru) * 2008-12-11 2011-02-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Средство против вирусов: энцефаломиокардита, гриппа а, простого герпеса 2
RU2404793C1 (ru) * 2009-06-04 2010-11-27 Общество с ограниченной ответственностью Био Пептид Стимулятор половой, сексуальной и репродуктивной функции
EA013948B1 (ru) * 2009-06-08 2010-08-30 Общество С Ограниченной Ответственностью "Витанта" Средство, активирующее половую функцию
RU2507212C3 (ru) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" Способ получения рекомбинантного пептида и полученный пептид

Also Published As

Publication number Publication date
US20170158735A1 (en) 2017-06-08
IN2014DN08984A (pl) 2015-05-22
RU2012111965A (ru) 2013-10-10
ES2768300T3 (es) 2020-06-22
RU2507212C2 (ru) 2014-02-20
CA2868820C (en) 2021-09-21
RU2507212C3 (ru) 2022-05-04
EP2876113A4 (en) 2017-03-01
IL234753B (en) 2018-11-29
BR112014023888B1 (pt) 2021-12-07
WO2013151467A2 (ru) 2013-10-10
PT2876113T (pt) 2020-02-03
US20150111837A1 (en) 2015-04-23
BR112014023888A2 (pt) 2018-05-29
EP2876113B1 (en) 2019-11-06
DK2876113T3 (da) 2020-02-03
CA2868820A1 (en) 2013-10-10
WO2013151467A3 (ru) 2014-01-09
EP2876113A2 (en) 2015-05-27
US9409947B2 (en) 2016-08-09
EP3650457A1 (en) 2020-05-13
EP3650457B1 (en) 2021-03-17

Similar Documents

Publication Publication Date Title
IL229247A0 (en) polypeptide
ZA201407992B (en) System and method for a compressor
SG11201400432VA (en) Polypeptide vaccine
SG11201504694VA (en) Method for producing a recombinant protein of interest
IL285503A (en) A method for producing high quality recombinant allergens in a plant
EP2897569A4 (en) COVER FOR RECOVERY PROCESSES AND METHOD FOR THE PRODUCTION THEREOF
EP2761014A4 (en) RECOMBINANT PHAGE AND METHOD
ZA201408719B (en) Surface covering system and method for producing such a system
IL235815A0 (en) System and method for predicting peptide immunogenicity
ZA201401140B (en) Polypeptide separation methods
GB201111183D0 (en) Peptide
GB201303183D0 (en) Method and apparatus for making a composite structure
GB201115910D0 (en) Peptides
IL234753B (en) A method for preparing a recombinant peptide and the prepared peptide
EP2599787A4 (en) PROCESS FOR PEPTIDE MANUFACTURE
EP2905260A4 (en) PROCESS FOR PRODUCING COMPOSITE OXIDE AND COMPOSITE OXIDE CATALYST
SG11201405721VA (en) Method of producing a recombinant peptide
ZA201502778B (en) Glycoprotein hormone long-acting superagonists
EP2599786A4 (en) PROCESS FOR PEPTIDE MANUFACTURE
IL220941A0 (en) Method for producing recombinant virus
HRP20171052T1 (hr) Lijevani dio i postupak za proizvodnju takvog lijevanog dijela
GB201106130D0 (en) Polypeptide
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201210286D0 (en) Recombinant polypeptide